Mar,06,2026
Keratin has garnered extensive attention due to its outstanding mechanical properties, thermal stability, and bioactive functions such as promoting hemostasis and wound healing. Traditionally, keratin is extracted from natural sources like human hair, wool, and feathers and processed into biomaterials such as thin films, hydrogels, and nanoparticles for biomedical applications. However, conventional extraction methods often yield heterogeneous keratin mixtures containing residual impurities and structural damage caused by stringent purification conditions, which complicates the investigation of how specific keratins and their hierarchical assemblies contribute to the desired material performance. Recombinant keratin technology addresses these challenges by enabling the synthesis of single keratin types with high purity and batch-to-batch consistency. These advances have facilitated in-depth studies on how keratin’s behavior at different assembly stages—from molecular components and heterodimers to intermediate filaments and their networks—impacts material properties. Moreover, this technology allows for precise genetic modification, holding promise for the development of keratin variants with tailored characteristics for specific applications. Despite these advantages, translating recombinant keratin into practical applications still requires overcoming key manufacturing hurdles, such as optimizing large-scale production and enhancing purification efficiency. This review summarizes the current state of research on recombinant keratin, highlights recent technological advances, and explores its applications in contemporary biomaterials. Although its current use remains more limited compared with extracted keratin, recombinant keratin holds great potential for advanced materials design and other non-medical fields.
Read More
Mar,2026
Keratin has garnered extensive attention due to its outstanding mechanical properties, thermal stability, and bioactive functions such as promoting hemostasis and wound healing. Traditionally, keratin is extracted from natural sources like human hair, wool, and feathers and processed into biomaterials such as thin films, hydrogels, and nanoparticles for biomedical applications. However, conventional extraction methods often yield heterogeneous keratin mixtures containing residual impurities and structural damage caused by stringent purification conditions, which complicates the investigation of how specific keratins and their hierarchical assemblies contribute to the desired material performance. Recombinant keratin technology addresses these challenges by enabling the synthesis of single keratin types with high purity and batch-to-batch consistency. These advances have facilitated in-depth studies on how keratin’s behavior at different assembly stages—from molecular components and heterodimers to intermediate filaments and their networks—affects material properties. Moreover, this technology permits precise genetic modification, holding promise for the development of keratin variants with tailored characteristics for specific applications. Despite these advantages, translating recombinant keratin into practical applications still requires overcoming key manufacturing challenges, such as optimizing large-scale production and enhancing purification efficiency. This review summarizes the current state of research on recombinant keratin, highlights recent technological advances, and explores its applications in contemporary biomaterials. Although its current use remains more limited compared with extracted keratin, recombinant keratin holds great potential for advanced materials design and other non-medical fields.